Unlocking comprehensive genomes for large-scale projects

Comprehensive genome analyses that provide information on single-nucleotide polymorphisms, structural variants, copy number variations and epigenetic markers are changing the landscape of genomics.

In this webinar, you’ll discover projects from Genomics England and deCODE genetics that are using nanopore sequencing to identify novel and known variants and provide greater insights into hundreds to thousands of samples.

Greg Elgar will discuss how Genomics England is examining the potential utility of using nanopore sequencing in the clinic as a test for rare diseases and cancer.

Brynja Sigurpálsdóttir will then explore how nanopore sequencing can be employed to detect CpG methylation and identify correlations between gene expression and epigenetic modifications.

Attend this webinar to:

• Explore how nanopore sequencing is being used for large-scale projects across Europe.
• Learn about the types of variation and rich data accessible with nanopore sequencing.
• Discover more about the potential clinical utility of using nanopore sequencing at scale.